Companion Diagnostic Market-Amplifies Impressively; is Expected to Grow at a Rate of About 6.1% from 2017 to 2023
Companion Diagnostics Market Information: By Technology (PCR, ISH, Immunohistochemistry), Indication (Cancer, Infectious Diseases, Cardiovascular Diseases, CNS Diseases), End User (Pharma & Biotech, Clinical Laboratories, CRO) – Global Forecast till 2023
(EMAILWIRE.COM, October 11, 2017 ) Executive Summary:
Market Research Future published new report, titled “Companion Diagnostic Market -Research Report: Global Forecast till 2023”.
Market Synopsis of Global Insulin Pump Market
Market Highlights
The global companion diagnostics market is expected to show steady growth owing to the demand for new diagnostic tests and devices for cancer and other life threatening diseases. Furthermore, growing emphasis on early diagnosis and treatment of cancer may lead to an increase in the demand for diagnostic services in developing countries.
On the other hand, there are some hindering factors which are restricting the market growth. Incorrect results from the test can lead to inadequate treatment being given to the patient, leading to the serious complications and adverse effects. The inaccuracy in tests sometimes increases the risk factor for the patients and in turn hinders the growth of the market.Furthermore, high cost of robust diagnostic devices such as PCR machine may restrain the market growth.
According to the American Cancer Society, prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers and among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common. Furthermore, the market is expected to grow in Asia Pacific due to an increase in the burden for cancer in this region.
Taste the market data and market information presented through more than 87 market data tables and 39 figures spread over 107 numbers of pages of the project report. Avail the in-depth TOC & market synopsis on “Companion Diagnostics Market Research Report –Global Forecast to 2023.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/3077
Market Scenario:
Companion diagnostics are the tests and tools used to determine the effect of a drug molecule on particular patients and also the potential patients who can be benefited by a specific treatment. The use of companion diagnostic treatments is an exciting aspect of medical development. The potential merit of companion diagnostics for patients is safer treatment with improved outcomes. The focus of medicine has always been on the patient’s wellbeing but with medicine becoming an increasing burden on taxpayers, reducing the cost of quality care is now of prime importance. Companion diagnostics offer an innovative way to achieve a better quality of care at a reduced price. Globally, the market for companion diagnostics is growing rapidly.
Globally, the market for companion diagnostics is expected to grow at a rate of about 6.1% from 2017 to 2023.
Global companion diagnostics market is driven by increasing prevalence of chronic diseases, high cost involved in the discovery and development of the drug and rising need for the assessment of drug efficacy and as well as drug safety.
Furthermore, increase in the demand for diagnostic devices for early detection tumors in case of acute diseases like cancer also boost the market growth.
High cost of robust diagnostic devices such as PCR machine may restrain the market growth.
Regional Analysis:
America is the largest market for companion diagnostics. In Americas, North America is the major contributor to the companion diagnostics market owing to an expensive use of advanced diagnostics devices driven by the alarming need for cancer diagnostics and treatment.
Europe is the second largest market after Americas owing to the growth of new technologies for cancer diagnostics in Europe, rising demand for efficiency in healthcare and strengthening healthcare system. Germany is the largest market in Europe followed by U.K.
Asia Pacific market is expected to be the fastest growing market for companion diagnostics due to continuous developments in developing countries such as India and China, and increasing healthcare expenditure in these countries. Rising prevalence of lifestyle disease such as diabetes, obesity and cancers also boost the market growth in Asia Pacific.
Middle East & Africa are expected to have a limited but steady growth owing to low healthcare expenditure and demand for primary healthcare services in this region.
Segmentation:
The global companion diagnostics market has been segmented on the basis of technology which comprises of Polymerase Chain Reaction (PCR), In-situ hybridization, and immunohistochemistry. On the basis of application, market is segmented into cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others. On the basis of end user, market is segmented into pharmaceutical & biotech companies, clinical laboratories, CRO, and other.
Global Companion diagnostics Market Players:
The major participants of this market are Abbott (U.S.), Agilent Technologies (U.S.), ARUP Laboratories (U.S.), F. Hoffmann-La Roche AG. (Germany), Myriad Genetics Inc. (U.S.), QIAGEN N.V. (Germany), and Thermo Fisher Scientific Inc. (U.S.).
BROWSE FULL REPORT DETAILS @ https://www.marketresearchfuture.com/reports/companion-diagnostic-market-3077
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future published new report, titled “Companion Diagnostic Market -Research Report: Global Forecast till 2023”.
Market Synopsis of Global Insulin Pump Market
Market Highlights
The global companion diagnostics market is expected to show steady growth owing to the demand for new diagnostic tests and devices for cancer and other life threatening diseases. Furthermore, growing emphasis on early diagnosis and treatment of cancer may lead to an increase in the demand for diagnostic services in developing countries.
On the other hand, there are some hindering factors which are restricting the market growth. Incorrect results from the test can lead to inadequate treatment being given to the patient, leading to the serious complications and adverse effects. The inaccuracy in tests sometimes increases the risk factor for the patients and in turn hinders the growth of the market.Furthermore, high cost of robust diagnostic devices such as PCR machine may restrain the market growth.
According to the American Cancer Society, prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers and among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common. Furthermore, the market is expected to grow in Asia Pacific due to an increase in the burden for cancer in this region.
Taste the market data and market information presented through more than 87 market data tables and 39 figures spread over 107 numbers of pages of the project report. Avail the in-depth TOC & market synopsis on “Companion Diagnostics Market Research Report –Global Forecast to 2023.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/3077
Market Scenario:
Companion diagnostics are the tests and tools used to determine the effect of a drug molecule on particular patients and also the potential patients who can be benefited by a specific treatment. The use of companion diagnostic treatments is an exciting aspect of medical development. The potential merit of companion diagnostics for patients is safer treatment with improved outcomes. The focus of medicine has always been on the patient’s wellbeing but with medicine becoming an increasing burden on taxpayers, reducing the cost of quality care is now of prime importance. Companion diagnostics offer an innovative way to achieve a better quality of care at a reduced price. Globally, the market for companion diagnostics is growing rapidly.
Globally, the market for companion diagnostics is expected to grow at a rate of about 6.1% from 2017 to 2023.
Global companion diagnostics market is driven by increasing prevalence of chronic diseases, high cost involved in the discovery and development of the drug and rising need for the assessment of drug efficacy and as well as drug safety.
Furthermore, increase in the demand for diagnostic devices for early detection tumors in case of acute diseases like cancer also boost the market growth.
High cost of robust diagnostic devices such as PCR machine may restrain the market growth.
Regional Analysis:
America is the largest market for companion diagnostics. In Americas, North America is the major contributor to the companion diagnostics market owing to an expensive use of advanced diagnostics devices driven by the alarming need for cancer diagnostics and treatment.
Europe is the second largest market after Americas owing to the growth of new technologies for cancer diagnostics in Europe, rising demand for efficiency in healthcare and strengthening healthcare system. Germany is the largest market in Europe followed by U.K.
Asia Pacific market is expected to be the fastest growing market for companion diagnostics due to continuous developments in developing countries such as India and China, and increasing healthcare expenditure in these countries. Rising prevalence of lifestyle disease such as diabetes, obesity and cancers also boost the market growth in Asia Pacific.
Middle East & Africa are expected to have a limited but steady growth owing to low healthcare expenditure and demand for primary healthcare services in this region.
Segmentation:
The global companion diagnostics market has been segmented on the basis of technology which comprises of Polymerase Chain Reaction (PCR), In-situ hybridization, and immunohistochemistry. On the basis of application, market is segmented into cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others. On the basis of end user, market is segmented into pharmaceutical & biotech companies, clinical laboratories, CRO, and other.
Global Companion diagnostics Market Players:
The major participants of this market are Abbott (U.S.), Agilent Technologies (U.S.), ARUP Laboratories (U.S.), F. Hoffmann-La Roche AG. (Germany), Myriad Genetics Inc. (U.S.), QIAGEN N.V. (Germany), and Thermo Fisher Scientific Inc. (U.S.).
BROWSE FULL REPORT DETAILS @ https://www.marketresearchfuture.com/reports/companion-diagnostic-market-3077
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Information:
Marketresearchfuture
Market Research Future
Tel: +1 (646) 845 9349
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Marketresearchfuture
Market Research Future
Tel: +1 (646) 845 9349
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results